Interventional cardiologists discuss the importance of choosing the right transcatheter heart valve for their patients, starting with the index procedure, and the benefits of the SAPIEN platform for optimal patient lifetime management.
Watch
Robert Welsh, MD, discusses the importance of choosing the optimal first valve for AS patients, considering potential future interventions and lifetime management.
Albrecht Schmidt, MD; Christian Hengstenberg, MD; and Robert Welsh, MD, discuss the importance and types of PVL, and how the SAPIEN platform delivers on achieving this optimal outcome.
With patients living longer, choosing the right valve from the start for a potential future implant is essential. Christian Hengstenberg, MD, and Albert Schmidt, MD, discuss why choosing the SAPIEN platform is an ideal move.
Robert Welsh, MD; Mirvat Alasnag, MD; and Ran Kornowski, MD, provide their perspectives on implanting a durable valve with confidence that it will last.
Considering a potential PCI for a patient is key when selecting a valve. Sam Dawkins, MD, and Mirvat Alasnag, MD, discuss how the SAPIEN platform is designed to help facilitate future coronary access.
Thank you for signing up to the heartvalves.com newsletter. You will now receive emails on the latest developments and industry insights on heart valve innovation and technology.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN 3, Edwards SAPIEN 3 Ultra, SAPIEN, SAPIEN 3, and SAPIEN 3 Ultra are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property if ther respective owners.
PP--EU-8300 v1.0